Team:Westminster/Protocols

From 2012.igem.org

(Difference between revisions)
Line 206: Line 206:
<p>The USER mix components are mixed (Table in materials).The PCR product must be purified before used in USER cloning
<p>The USER mix components are mixed (Table in materials).The PCR product must be purified before used in USER cloning
<p>● 2 µl of the USER mix is transferred to PCR tubes.</p>
<p>● 2 µl of the USER mix is transferred to PCR tubes.</p>
-
<p>● The PCR products is added in equal amounts of each and incubated for 40 minutes at 37°C and for 30 min at 25°C.</p> <img src="https://static.igem.org/mediawiki/2012/1/1c/User_Mix.png" alt="USER" title="USER Mix" />
+
<p>● The PCR products is added in equal amounts of each and incubated for 40 minutes at 37°C and for 30 min at 25°C.</p> <img src="https://static.igem.org/mediawiki/2012/1/1c/User_Mix.png" alt="USER" title="USER Mix" />  
-
 
+
<h2>Site-Directed Mutagenesis</h2>
-
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
+
<p>• Purify template plasmid DNA from a dam+ Escherichia coli strain (to ensure that all GATC sites are methylated for later digestion with DpnI).</p>
 +
<p>• Design forward and reverse primers that will bind to the region of DNA you want to mutate but that contain the modifications you wish to make. See the CAD tool PrimerX.</p>
 +
<p>• Run a primer-extension reaction with a proof-reading, non-displacing polymerase such as Pfu DNA polymerase. This results in nicked circular strands of the plasmid.</p>
 +
<p>• Cut up the template DNA with DpnI.</p>
 +
<p>• Transform the circular nicked DNA into a highly competent strain such as XL1-Blue. These cells will repair the nicks and not restrict the unmodified product DNA.</p>
 +
<p>• Select colonies with the correct DNA.
 +
</p>
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
<p>Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.</p>
<img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" width="885" height="220" />
<img src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" alt="Welcome" title="Welcome to our home!" width="885" height="220" />

Revision as of 18:37, 26 September 2012

Welcome

AMPLIFICATION OF GENOMIC DNA

Cell Lysis

We used Stratagene kit for lysing human cells and extracting DNA.

• Pellet up to a maximum of 1x 106 cells for 30 sec. in microfuge. If more than 1X 106 cells are used, the reagent volumes will have to be increased accordingly. For adherent cells, a trypsin treatment is generally used prior to this step to free the cells into suspension. Be careful to perform the trypsin step in a timely manner so that5 the cells do not remain in undiluted trypsin for a long period of time.

• Aspirate media and wash cells with 500 l of 1x PBS.

• Pellet cells 30 sec. in microfuge at 14, 000 rpm. • Aspirate PBS and resuspend cells in 500 l of PBS. Repeat spin and aspiration steps. • Resuspend cells in 100 l PBS and 200l sterile water. • Lyse cells by heating to 950C for 10-15 minutes. • Allow the cells to cool briefly by setting at room temperature for 5 min. And add 10 l of 10 mg/ml Proteinase K to each sample. Quick vortex to mix. • Incubate at 550C for one hour. • Inactivate Proteinase K by heating to 950c for 10 minutes. • Spin down condensation. • Store at -200c.

PCR Amplification

Biolabs Phusion High- Fidelity DNA polymerase was used for all PCR amplifications. The reactions and conditions are given below.

Phusion

Conditions:

Phusion

PCR amplification with linkers required an additional 50 M Mg2+ in the mastermix.

USER Amplification

Procedure

The USER mix components are mixed (Table in materials).The PCR product must be purified before used in USER cloning

● 2 µl of the USER mix is transferred to PCR tubes.

● The PCR products is added in equal amounts of each and incubated for 40 minutes at 37°C and for 30 min at 25°C.

USER

Site-Directed Mutagenesis

• Purify template plasmid DNA from a dam+ Escherichia coli strain (to ensure that all GATC sites are methylated for later digestion with DpnI).

• Design forward and reverse primers that will bind to the region of DNA you want to mutate but that contain the modifications you wish to make. See the CAD tool PrimerX.

• Run a primer-extension reaction with a proof-reading, non-displacing polymerase such as Pfu DNA polymerase. This results in nicked circular strands of the plasmid.

• Cut up the template DNA with DpnI.

• Transform the circular nicked DNA into a highly competent strain such as XL1-Blue. These cells will repair the nicks and not restrict the unmodified product DNA.

• Select colonies with the correct DNA.

Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.

Welcome